TY - JOUR
T1 - Confirmation of the Type 2 Myotonic Dystrophy (CCTG)n Expansion Mutation in Patients with Proximal Myotonic Myopathy/Proximal Myotonic Dystrophy of Different European Origins
T2 - A Single Shared Haplotype Indicates an Ancestral Founder Effect
AU - Bachinski, Linda L.
AU - Udd, Bjarne
AU - Meola, Giovanni
AU - Sansone, Valeria
AU - Bassez, Guillaume
AU - Eymard, Bruno
AU - Thornton, Charles A.
AU - Moxley, Richard T.
AU - Harper, Peter S.
AU - Rogers, Mark T.
AU - Jurkat-Rott, Karin
AU - Lehmann-Horn, Frank
AU - Wieser, Thomas
AU - Gamez, Josep
AU - Navarro, Carmen
AU - Bottani, Armand
AU - Kohler, Andre
AU - Shriver, Mark D.
AU - Sallinen, Riitta
AU - Wessman, Maija
AU - Zhang, Shanxiang
AU - Wright, Fred A.
AU - Krahe, Ralf
N1 - Funding Information:
We are grateful to the participating families for their cooperation. R.K. would like to thank N. Z. Moore and T. Ahmed, for assistance, and S. Colella, for advice on pyrosequencing, as well as D. Lee, S. McWhinney, M. Holloway, X. Gao, and D. Wang, for assistance, and the Human Cancer Genetics Program Genotyping-Sequencing Unit (Ohio State University), for technical assistance with genotyping in the early stages of this study. Samples from two German families with PROMM/DM2 (D01 and D02) were also studied by L. P. W. Ranum and colleagues in a separate study. We thank the Association Française contre les Myopathies for their support with the procurement of French patient samples. We wish to thank the European Neuro-Muscular Centre for their continued support of the International Working Group on DM2/PROMM and Other Myotonic Dystrophies. This study was supported by grants from the Juselius Foundation, Ohio State University, Muscular Dystrophy Association U.S.A., the National Institutes of Health (grant R01 AR48171 and, in part, grant P30 CA16058, both to R.K.), Medicinska understödsföreningen Liv och Hälsa r.f. (to B.U.), the Folkhälsan Institute of Genetics (to R.K. and B.U.), MURST-Italy (to G.M.), the Research and Science Foundation of Farmos, and the Research Foundation of the University of Helsinki (to R.S.).
PY - 2003/10/1
Y1 - 2003/10/1
N2 - Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, is a clinically and genetically heterogeneous neuromuscular disorder. DM is characterized by autosomal dominant inheritance, muscular dystrophy, myotonia, and multisystem involvement. Type 1 DM (DM1) is caused by a (CTG) n expansion in the 3′ untranslated region of DMPK in 19q13.3. Multiple families, predominantly of German descent and with clinically variable presentation that included proximal myotonic myopathy (PROMM) and type 2 DM (DM2) but without the DM1 mutation, showed linkage to the 3q21 region and were recently shown to segregate a (CCTG)n expansion mutation in intron 1 of ZNF9. Here, we present linkage to 3q21 and mutational confirmation in 17 kindreds of European origin with PROMM and proximal myotonic dystrophy, from geographically distinct populations. All patients have the DM2 (CCTG) n expansion. To study the evolution of this mutation, we constructed a comprehensive physical map of the DM2 region around ZNF9. High-resolution haplotype analysis of disease chromosomes with five micro satellite and 22 single-nucleotide polymorphism markers around the DM2 mutation identified extensive linkage disequilibrium and a single shared haplotype of at least 132 kb among patients from the different populations. With the exception of the (CCTG)n expansion, the available markers indicate that the DM2 haplotype is identical to the most common haplotype in normal individuals. This situation is reminiscent of that seen in DM1. Taken together, these data suggest a single founding mutation in DM2 patients of European origin. We estimate the age of the founding haplotype and of the DM2 (CCTG) expansion mutation to be ∼200-540 generations.
AB - Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, is a clinically and genetically heterogeneous neuromuscular disorder. DM is characterized by autosomal dominant inheritance, muscular dystrophy, myotonia, and multisystem involvement. Type 1 DM (DM1) is caused by a (CTG) n expansion in the 3′ untranslated region of DMPK in 19q13.3. Multiple families, predominantly of German descent and with clinically variable presentation that included proximal myotonic myopathy (PROMM) and type 2 DM (DM2) but without the DM1 mutation, showed linkage to the 3q21 region and were recently shown to segregate a (CCTG)n expansion mutation in intron 1 of ZNF9. Here, we present linkage to 3q21 and mutational confirmation in 17 kindreds of European origin with PROMM and proximal myotonic dystrophy, from geographically distinct populations. All patients have the DM2 (CCTG) n expansion. To study the evolution of this mutation, we constructed a comprehensive physical map of the DM2 region around ZNF9. High-resolution haplotype analysis of disease chromosomes with five micro satellite and 22 single-nucleotide polymorphism markers around the DM2 mutation identified extensive linkage disequilibrium and a single shared haplotype of at least 132 kb among patients from the different populations. With the exception of the (CCTG)n expansion, the available markers indicate that the DM2 haplotype is identical to the most common haplotype in normal individuals. This situation is reminiscent of that seen in DM1. Taken together, these data suggest a single founding mutation in DM2 patients of European origin. We estimate the age of the founding haplotype and of the DM2 (CCTG) expansion mutation to be ∼200-540 generations.
UR - http://www.scopus.com/inward/record.url?scp=0142027590&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0142027590&partnerID=8YFLogxK
U2 - 10.1086/378566
DO - 10.1086/378566
M3 - Article
C2 - 12970845
AN - SCOPUS:0142027590
SN - 0002-9297
VL - 73
SP - 835
EP - 848
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 4
ER -